X-116444944-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The ENST00000598581.3(SLC6A14):c.683G>A(p.Gly228Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000911 in 1,208,046 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000598581.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A14 | NM_007231.5 | c.683G>A | p.Gly228Glu | missense_variant | 6/14 | ENST00000598581.3 | NP_009162.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A14 | ENST00000598581.3 | c.683G>A | p.Gly228Glu | missense_variant | 6/14 | 1 | NM_007231.5 | ENSP00000470801 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111749Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33953
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 182115Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66747
GnomAD4 exome AF: 0.00000821 AC: 9AN: 1096297Hom.: 0 Cov.: 28 AF XY: 0.00000553 AC XY: 2AN XY: 361857
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111749Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33953
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2023 | The c.683G>A (p.G228E) alteration is located in exon 6 (coding exon 6) of the SLC6A14 gene. This alteration results from a G to A substitution at nucleotide position 683, causing the glycine (G) at amino acid position 228 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at